SiTime Corp (SITM) Form 8-K Summary
Business Context and Reporting Period
SiTime Corporation, a Delaware corporation, filed this Current Report on Form 8-K on June 25, 2025. The filing discloses the execution of an Underwriting Agreement for a public offering of common stock. The Company's principal executive offices are located in Santa Clara, California.
Key Financial Metrics and Offering Details
This filing does not report operational financial metrics such as revenue, profit, cash flow, margins, or debt levels. The primary financial data relates to the capital raise:
- Shares Offered: 1,750,000 shares of Common Stock.
- Offering Price: $200.00 per share.
- Over-Allotment Option: Underwriters have a 30-day option to purchase up to an additional 262,500 shares.
- Expected Closing Date: June 27, 2025, subject to customary conditions.
- Underwriters: UBS Securities LLC and Stifel, Nicolaus & Company, Incorporated (Joint Lead Book-Running Managers); Needham & Company, LLC and Goldman Sachs & Co. LLC (Joint Book-Running Managers); Raymond James & Associates, Inc. and Roth Capital Partners, LLC (Co-Managers).
Material Changes
The filing announces a material change in the Company's capital structure through the issuance of new equity. The offering is being made pursuant to an effective shelf registration statement on Form S-3 filed on February 26, 2024. No other material changes to operations or financial condition are disclosed in this specific report.
Guidance, Outlook, and Risks
The filing contains no management commentary, financial guidance, or outlook for future periods. It notes that the Underwriting Agreement includes customary representations, warranties, indemnification obligations, and termination provisions. The description of the agreement is qualified by reference to the full text filed as Exhibit 1.1.
Investor Verification Checklist
- Verify the final closing of the offering on or after June 27, 2025.
- Confirm whether the underwriters exercised the 30-day option to purchase the additional 262,500 shares.
- Review the final prospectus supplement dated June 25, 2025, for specific use of proceeds and risk factors.
- Check subsequent filings for the impact of this equity issuance on share count and dilution.